Game,

IMO the share price for Cardiogenics has no chance of moving above a dollar a share without data from a clinical trial being published demonstrating statistically significant performance of the silver coated beads in the POC analyzer. Without this data IMO the promise of Cardiogenics' technology will not be recognized and the commercial potential of the Company will not be reflected in its share price.

Ante